Alpha Teknova Inc
Research Alpha Teknova Inc (TKNO) on Bullrun: market cap USD 400.47M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTKNO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 400.47M
- Financial periodQ2 2026
- RevenueUSD 12.19M
- Net income-USD 3.17M
- Free cash flow-USD 596.00K
- Gross margin40.1%
Valuation Snapshot
latest market cap is USD 400.47M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 40.52M | -USD 17.26M | -USD 9.79M | 33.2% | -0.32 | USD 5.91M | USD 13.12M | USD 68.78M |
| FY2024 | USD 37.75M | -USD 26.75M | -USD 13.52M | 19.2% | -0.57 | USD 3.71M | USD 13.49M | USD 82.39M |
| FY2023 | USD 36.68M | -USD 36.78M | -USD 26.75M | 28.1% | -1.16 | USD 28.48M | USD 13.25M | USD 90.04M |
| FY2022 | USD 41.42M | -USD 47.47M | -USD 55.55M | 42.2% | -1.69 | USD 42.24M | USD 21.98M | USD 99.89M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 400.47M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 203.54M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 445.97M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 151.91M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 158.66M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 573.69M | n/a | n/a | n/a |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Alpha Teknova Inc's market cap?
Alpha Teknova Inc's market capitalization is USD 400.47M.
What does Alpha Teknova Inc do?
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.